TikTok Moment For BeiGene, Junshi As FDA Looks At China PD-1s
At Least One To Score Approval?
Amid deepening bilateral decoupling and geopolitical tensions, the US regulatory agency is sending field inspectors to China for the first time in three years as it moves forward in reviewing and potentially approving the first 'Made In China' immuno-oncology drugs.
